Rittenhouse Ventures today announced the final closing of Rittenhouse Fund II.
At $18 million of committed capital, Rittenhouse II builds upon the firm’s strong performance in the Rittenhouse Fund I portfolio, which includes Tabula Rasa Healthcare, Core Solutions,Halfpenny Technologies, and Take the Interview.
“Our mission is to partner with entrepreneurs to deliver right-sized investments, deep expertise, regional relationships, and successful financial outcomes,” said Saul Richter, Co-Founder and Managing Partner. “We greatly appreciate our investors’ shared vision in our focused investment strategy.”
Investors in Rittenhouse Fund II include Ben Franklin Technology Partners and Innovate in PA, run by the Commonwealth of Pennsylvania, along with distinguished individuals—CEOs, investors, and industry experts. “We’ve been proud to be part of the Rittenhouse story from the start,” said Ben Franklin President and CEO, RoseAnn B. Rosenthal. “The Rittenhouse team is aligned with our focus on delivering the right capital and guidance to growing technology companies. They carefully execute an investment strategy that helps our region flourish in exciting ways.”
Read the full article here.